uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 28, 2017

Seller of Prostate, Reishi Supplements Warned for Manufacturing Violations

On September 11, 2017, the FDA issued a warning letter to Vicare International (USA), Inc., following facility inspections which found a number of the company's products, including VI — DiabeCare, VI — Prosta Care, VI — Sheep Placenta, VI — Vessel Care II, VI — LiverCare, Nu — DiabeCare, Nu — Sheep Placenta, Nu — Prosta Care, Nu — Angio Care, Nu — LiverCare, Vicare Vi-Reishi, NuLife Nu-Reishi, and Vicare Super Cell to be adulterated because they were prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements.

These violations include failing to establish specifications for each dietary supplement and for the identity and strength of the finished batch of the dietary supplement to ensure quality, and failure to establish specifications for product labels and packaging, as required by federal regulations.

See's Review of Prostate Supplements for tests of related products.

Also see the CL Answer: Do reishi mushroom supplements boost the immune system, or have other benefits? >>

See related warnings:

Seller of Alpha Lipoic Acid, Cinnamon Supplements and More Warned For Manufacturing Violations

FDA Warns Seller of Menopause, Sexual Enhancement, Prostate Supplements and More For Manufacturing Violations

Seller of Prostate, Immune Supplements & More Warned for Manufacturing Violations

FDA Warns Seller of Probiotic and Omega-3 Supplements for Manufacturing Violations

To read the FDA's warning letter, use the link below.